ILife Consulting


France-based contract research organisation (CRO) founded in 2013 providing clinical development and operations services for small and mid-sized life science companies. Offers end-to-end clinical trial support including strategy, project management, regulatory submissions (Europe/US), clinical monitoring, medical writing, vendor coordination and training. Focuses on early-phase (Phase I/II) development with experience in oncology and supports trial execution across Europe with partnerships for North American monitoring.

Industries

biopharma
biotechnology
clinical-trials

Nr. of Employees

small (1-50)

ILife Consulting

Paris, Ile-de-France, France, Europe


Services

Operational delivery of clinical trials including feasibility, study start-up, monitoring, site management, data oversight and study close-out.

Strategic planning for clinical programs, study design (including basket studies), gap analyses and alignment with business KPIs.

Preparation and management of submissions to competent authorities and ethics committees in Europe, and support for IND/CTA processes in the USA.

Provision of local and freelance CRAs, site training, co-monitoring, on-site and remote monitoring, and site performance oversight.

Authorship and review of essential clinical documents including protocols, CRFs, ICFs, monitoring plans and SOPs.

Recruitment of clinical staff and on-the-job training to regulatory and GCP standards provided by experienced clinical project managers.

View All Services

Expertise Areas

  • Clinical trial management
  • Clinical development strategy
  • Regulatory submission and EU/US ethics processes
  • Phase I/II oncology development and basket studies
  • Show More (8)

Key Technologies

  • Clinical trial management systems (CTMS)
  • Electronic case report forms (eCRF)
  • Electronic patient-reported outcomes (eCOA / eDiary)
  • Interactive response technology (IRT)
  • Show More (5)

News & Updates

Recorded webinar featuring the CEO discussing the company's role in supporting clinical development and fundraising (video in French).

Case study describing interventions to identify and correct low recruitment in a dose-escalation Phase I/II glioblastoma study.

Case study on training and upskilling programs applied to an open-label multicenter interventional rollover trial.

Decision granting agrément recognising the company's capacity to perform R&D work for third parties for the years 2022, 2023 and 2024.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.